Improved exercise ventilatory efficiency with nasal compared to oral breathing in cardiac patients

Objectives: To assess whether nasal breathing improves exercise ventilatory efficiency in patients with heart failure (HF) or chronic coronary syndromes (CCS).

Background: Exercise inefficient ventilation predicts disease progression and mortality in patients with cardiovascular diseases. In healthy people, improved ventilatory efficiency with nasal compared to oral breathing was found.

Methods: Four study groups were recruited: Patients with HF, patients with CCS, old (age≥45 years) and young (age 20–40 years) healthy control subjects. After a 3-min warm-up, measurements of 5 min with once nasal and once oral breathing were performed in randomized order at 50% peak power on cycle ergometer. Ventilation and gas exchange parameters measured with spiroergometry were analysed by Wilcoxon paired-sample tests and linear mixed models adjusted for sex, height, weight and test order.

Results: Groups comprised 15 HF, CCS, and young control and 12 old control. Ventilation/carbon dioxide production ($\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂), ventilation ($\dot{\mathrm{V}}$_E), breathing frequency (f_R), and end-tidal oxygen partial pressure (P_ETO₂) were significantly lower and tidal volume and end-tidal carbon dioxide partial pressure (P_ETCO₂) significantly higher during nasal compared to oral breathing in all groups, with large effect sizes for most parameters. For patients with HF, median $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂ was 35% lower, f_R 26% lower, and P_ETCO₂ 10% higher with nasal compared to oral breathing, respectively. Exercise oscillatory ventilation (EOV) was present in 6 patients and markedly reduced with nasal breathing.

Conclusion: Nasal breathing during submaximal exercise significantly improved ventilatory efficiency and abnormal breathing patterns (rapid shallow breathing and EOV) in 80% of our patients with HF and CCS.

GRAPHICAL ABSTRACT

GRAPHICAL ABSTRACT | Presentation of the study groups and study protocol (top panels). Nasal breathing resulted in a pattern of slower and deeper breathing and a reduced ventilation to carbon dioxide production in all groups (lower panels).

1 Introduction

An exaggerated ventilatory response to exercise, often accompanied by early exertional dyspnea, is a hallmark in patients with chronic heart failure (HF) (Chua et al., 1996; Tomita et al., 2003). It has also been reported in patients with chronic coronary syndromes (CCS) and left ventricular dysfunction (Eser et al., 2023). Ventilatory inefficiency has not only been associated with reduced exercise capacity and quality of life but also with poorer prognosis (Ponikowski et al., 2001; Arena et al., 2004; Nadruz et al., 2017). It is quantified by an increased $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂-slope, arising from an excessive rise of minute ventilation ($\dot{\mathrm{V}}$_E) with respect to carbon dioxide production ($\dot{\mathrm{V}}$CO₂) in the absence of metabolic acidosis (Agostoni and Guazzi, 2017). Based on the modified alveolar Eq. 1 an increased $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂-slope can be explained by two factors: A reduced arterial CO₂ partial pressure (P_aCO₂) and/or a high fraction of the tidal volume (V_T) that goes to dead space (V_D) (i.e., the V_D/V_T-ratio) (Wang et al., 2020).

$\frac{V_E}{VC{O}_2}=\frac{863}{{P_{a}CO}_2\ast \left(1-\frac{V_D}{V_T}\right)}(1)$

Physiological dead space refers to the ventilated air that does not participate in gas exchange and is comprised of the anatomical dead space (i.e., the conducting airways) and the alveolar dead space (i.e., lung regions which are poorly perfused).

In patients with HF, impaired cardiac function may result in lung areas which are ventilated but poorly perfused (i.e., ventilation-perfusion mismatch) with $\dot{\mathrm{V}}$_E rising during exercise without sufficient rise in pulmonary perfusion (Weatherald et al., 2018). Furthermore, the V_D/V_T-ratio can be increased due to a reduced V_T during exercise when the diaphragm fatigues. Muscle fatigue in the diaphragm and/or the peripheral muscles leads to accumulating metabolites that trigger ergoreflexes which ellicit a steep increase in breathing frequency, (Piepoli et al., 1996), resulting in a pattern of rapid shallow breathing (RSB) (Weatherald et al., 2018). Increased chemosensitivity may further accelerate the abnormal ventilatory response to exercise in patients with HF (Chua et al., 1996; Ponikowski et al., 1997) and also in patients after acute myocardial infarction (Tomita et al., 2003). In patients with HF, the heart is enlarged and so restricts an appropriate increase in V_T (Cross et al., 2020). Consequently, in these patients ventilation is increased preferentially via an increase in breathing rate, again favoring a pattern of RSB.

Pharmaceutical as well as exercise therapies have been shown to reduce the exaggerated ventilatory response to exercise in patients with HF (Hambrecht et al., 1995). However, adherence to exercise recommendations may be poor in patients suffering from dyspnea, as exercise tolerance may be low (Cooper et al., 2015). There is an unmet need for further therapies to improve ventilatory efficiency and exercise tolerance. Slow breathing training has been shown to have positive effects on cardiorespiratory function, (Bernardi et al., 2002; Parati et al., 2008; Lachowska et al., 2019), and ventilatory efficiency (Parati et al., 2008) in patients with HF. Furthermore, in healthy volunteers it has been shown that nasal breathing can reduce the $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂ ratio during exercise compared to oral breathing (Dallam et al., 2018; LaComb et al., 2017). Increased airway resistance leads to reduced breathing frequency, which allows more time for diffusion in the lungs and therefore better oxygenation (Dallam and Kies, 2020; Rappelt et al., 2023). This is supported by increased P_ETCO₂ and decreased end-tidal oxygen partial pressure (P_ETO₂) levels during nasal breathing (Dallam et al., 2018; Rappelt et al., 2023).

To date, no study has investigated whether nasal breathing is feasible in patients with HF or CCS and whether it is accompanied by a lower $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO_2E/$\dot{\mathrm{V}}$CO₂-ratio compared to oral breathing. We aimed to close this gap in knowledge as these patients would be particularly prone to benefit from an improved breathing pattern and ventilatory efficiency during exercise.

The aims of the current study were to 1) Compare ventilatory efficiency and parameters of breathing pattern between oral and nasal breathing during submaximal exercise in patients with HF or CCS and inefficient ventilation; and 2) assess whether there is an age-related difference between oral and nasal breathing with regard to ventilatory efficiency by comparing healthy old volunteers (age-matched to the HF and CCS patients), and young healthy volunteers.

2 Methods

2.1 Study participants

This study was conducted as a sub-study of the Breathe-HF trial (NCT05057884). The sub-study included four different groups of participants, two cardiac patient groups and two healthy control groups. The inclusion and exclusion criteria are listed in Table 1. The rational for only including patients with $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂ slope ≥36 was that this parameter is an objective criteria reflecting exercise induced dyspnea. Our study intervention of slow nasal breathing training aimed to improve exercise breathing efficiency.

Table 1

Table 1. In- and exclusion criteria of the different groups’ study participants.

2.2 Study procedures

Eligible patients with HF and CCS were identified and recruited during their yearly check-up visit at a tertiary university referral centre. Healthy young and old volunteers were recruited by word of mouth. If they met the inclusion criteria and consented in writing, they were included in the study and measurements were performed as summarized in Supplementary Figure S1. The study was approved by the ethics committee of the Canton of Berne.

Body composition was assessed by bioelectrical impedance with a body composition analyzer (inbody 770, best4health gmbh, Bassersdorf, Switzerland). Weight, lean muscle mass, and body fat percentage were measured and reported for comparison of anthropometric characteristics between groups. Moreover, body mass index (BMI) was calculated.

2.3 Cardiopulmonary exercise testing

Exercise capacity was assessed with a CPET on a cycle ergometer. Prior to the test, a vital capacity (FCV, l) and forced expiratory volume in one second (FEV₁, l*min^-1) was assessed by spirometry. Then, after sitting on the ergometer quietly for 3 min, blood pressure was measured two times and the lowest measurement was recorded. A 3 min warm-up was followed by an individually set ramp as previously described (Eser et al., 2022). Volumes, flows and gases were sampled continuously in an open spirometric system (Quark, Cosmed, Rome, Italy) and averaged over 8 breaths, as recommended (Glaab and Taube, 2022). Measured variables included oxygen uptake ($\dot{\mathrm{V}}$O₂, ml*min⁻¹*kg⁻¹), carbon dioxide production ($\dot{\mathrm{V}}$CO₂ ml*min⁻¹), minute ventilation ($\dot{\mathrm{V}}$_E, l*min⁻¹), respiration frequency (f_R, breaths*min⁻¹), tidal volume (V_T, l) and end-tidal partial pressures of O₂ (P_ETO₂, mmHg) and CO₂ (P_ETCO₂, mmHg), heart rate (HR, beats*min^-1) and oxygen saturation (SpO₂, %). Additionally, the respiratory exchange ratio (RER = $\dot{\mathrm{V}}$CO₂/$\dot{\mathrm{V}}$O₂) and the oxygen pulse ($\dot{\mathrm{V}}$O₂/heart beat) were calculated. $\dot{\mathrm{V}}$O_2peak (ml*min⁻¹*kg⁻¹) was defined as the highest value of oxygen consumption averaged over 30 s. The first (VT1) and second ventilatory threshold (VT2) were identified using the Wassermann’s 9-panel plot (Marcin et al., 2020). The $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$ CO₂-slope was determined from the start of the ramp until VT2. Further, the nadir of the $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂-ratio was defined as the lowest $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂-ratio during exercise.

2.4 Oral and nasal submaximal tests

After the CPET following a 15-min resting period (or on a separate day if the CPET was performed as part of clinical routine testing), all subjects completed a submaximal constant load cycling protocol with exclusively oral and nasal breathing in randomized order. The protocol consisted of a 3 min warm-up phase followed by 5 min of constant load cycling at 50% of peak power output. This intensity was chosen based on a study by LaComb (LaComb et al., 2017) and the fact that some people have difficulties breathing through their nose at high intensities. During the oral breathing subjects were required to wear a nose clip under the mask, whereas during the nasal breathing their mouth was covered with tape.

Participants were instructed to always maintain a cadence of 60–70 min⁻¹. The two trials were separated by a 10-min break to allow for some recovery. Rating of perceived exertion (RPE) was noted upon completion of each trial in the patient groups. All parameters of breathing patterns and gas exchange were calculated as averages of the fifth minute. The rapid shallow breathing index (RSBI, m²*min⁻¹* l⁻¹) was calculated by dividing f_R by V_T. Exercise ventilatory oscillation (EOV) was defined according to guidelines (Guazzi et al., 2012).

2.5 Statistical analysis

All analyses were performed by R (R Core Team, 2021; Version 4.1.0). Primary outcome was the within-subject difference in $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$ CO₂-ratio between oral and nasal breathing modes. This was analysed by within group differences between oral and nasal breathing using paired Wilcoxon tests. Further, the effect of breathing mode was analysed by the group × mode interaction effect of a linear mixed model with package “nlme” (Version 3.1–152) with fixed effects breathing mode, patient/volunteer group, order of the nasal breathing mode, adjusted for sex, height and weight. Adjustment for age was not included as the effect of age was investigated by including an age-matched and a young control group. Subjects were entered as random intercepts. Effect sizes were calculated by the package “sjPlot” (version 2.8.6). Secondary outcomes were the differences between oral and nasal breathing in $\dot{\mathrm{V}}$e, V_T, f_R, P_ETO₂, P_ETCO₂, RSBI, $\dot{\mathrm{V}}$O₂, HR, and $\dot{\mathrm{V}}$O₂/HR averaged over the 5^th minute, all analyzed using linear mixed models as specified for the primary outcome. Old control subjects, oral breathing, first order and female patients were set as reference categories.

Baseline characteristics were tested between groups by Kruskal-Wallis tests followed by post hoc testing (only patient groups and young control subjects were tested against old control subjects) adjusted for multiple testing by Benjamini-Hochberg correction. Categorical variables were tested by Fisher’s exact tests. Statistical significance for all tests was set at a p-value <0.05.

3 Results

3.1 Study population

Fifteen young and 14 old healthy control subjects were recruited for the present study (Figure 1). Of patients with HF performing CPETs for yearly clinical visits, 59 qualified for inclusion. Eighteen could not be reached by phone and 26 declined participation in the study. Within the HF group, eleven patients were classified as having reduced (HFrEF), three as having mildly reduced (HFmrEF) and one as having preserved ejection fraction (HFpEF) (McDonagh et al., 2021). Of 53 patients with CCS qualifying for the study, 20 could not be contacted and 18 declined participation, leaving 15 who participated in the study. Two old healthy controls had a blocked nose and had to stop the nasal trial after 3 min, leaving data from 12 old healthy controls in the analyses. Otherwise the exercise bouts with the different breathing modes were tolerated well. There were no significant differences between old healthy control subjects and the two patient groups with regard to baseline characteristics (Table 2). The only significantly different baseline characteristics were age and percent body fat between old and young healthy control subjects.

Figure 1

Figure 1. Patient/participant flow of the four groups.

Table 2

Table 2. Baseline characteristics of included subjects. Shown are medians and first and third quartiles in round brackets for each group.

3.2 Results of cardiopulmonary exercise tests

Resting parameters of the two patient groups were comparable to old control subjects except for P_ETCO₂ that was lower in patient with CCS (Supplementary Table S1). The first ventilatory threshold occurred at lower power, lower VO₂, lower $\dot{\mathrm{V}}$_E and V_T relative to body weight in both patient groups compared to old control subjects. Based on the inclusion criteria for both patient groups, they had significantly higher $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂-slopes and nadir $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂. At peak exercise, power, VO_2, P_ETCO₂ and HR were lower than in the old control subjects (Supplementary Table S1).

3.3 Nasal compared to oral breathing

Non-parametric data of ventilatory and circulatory parameters during the submaximal cycling with nasal and oral breathing modes of the four different groups are shown in Table 3. Power output was constant between nasal and oral breathing and was comparable to power at VT1 (range −14% to 8%), indicating that the tests were completed during aerobic metabolism. Subjectively perceived exertion did not differ between breathing modes.

Table 3

Table 3. Ventilatory and circulatory parameters during 5 minutes of submaximal cycling with exclusively nasal or oral breathing. The intensity was set at 50% of their peak power achieved during the CPET. For each participant values were averaged over the 5^th minute. Shown are medians and first and third quartiles in round brackets for each group and each condition in randomized order.

Mean values during oral and nasal breathing of all primary and secondary outcome variables ($\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂-ratio, $\dot{\mathrm{V}}$_E, V_T, f_R, $\dot{\mathrm{V}}$O₂, P_ETO₂, P_ETCO₂, HR and $\dot{\mathrm{V}}$O₂/HR) analysed by linear mixed models are displayed in Figures 2, 3. Nasal breathing led to strong effect sizes in lowering $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂-ratio (standardized beta −0.64, p < 0.001), $\dot{\mathrm{V}}$e (−0.52, p = 0.004) and f_R (−0.78, p < 0.003) and small effect size for increasing V_T (0.29, p = 0.083, Supplementary Table S2). Specifically, median V_T was raised by nasal breathing significantly in all groups except old controls (Table 3). There was no effect on breathing mode on $\dot{\mathrm{V}}$O₂ in the old control subjects (Supplementary Table S2 and Figure 3), however, in the HF group median $\dot{\mathrm{V}}$O₂ was higher by 1.1 mL/kg/min or 7.6% (p = 0.007, Table 3). Lower f_R and higher V_T lead to a reduced RSBI (−0.41, p = 0.084, Supplementary Table S2 and Figure 2), whose median was reduced by 34.5% (p < 0.01) in the HF group (Table 3). Likewise, P_ETCO₂ levels were significantly higher (0.88, p < 0.001) and P_ETO₂ levels lower (−0.80, p < 0.001) in all groups (Supplementary Table S2 and Figure 2), albeit to a smaller degree in the patient groups. Within-subject differences between nasal and oral breathing modes are shown in Figure 4. HR was also not different between the two breathing modes and neither was oxygen pulse, the ratio between $\dot{\mathrm{V}}$O₂ and HR (Table 3, Figure 3).

Figure 2

Figure 2. Interaction plots of effects of breathing modes and groups on $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$ CO₂ slope, V_T, f_B, RSBI, P_ETO₂ and P_ETCO₂ adjusted for order, sex, height and weight. CHF, chronic heart failure; CCS, acute/chronic coronary syndrome; $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$ CO₂, ventilation to carbon dioxide production; V_T, tidal volume; f_B, breathing frequency; RSBI, rapid shallow breathing index; P_ETO₂, end tidal partial pressure of oxygen: P_ETCO₂, end tidal partial pressure of CO₂.

Figure 3

Figure 3. Interaction plots of effects of breathing modes and groups on $\dot{\mathrm{V}}$O₂, HR and oxygen pulse ($\dot{\mathrm{V}}$O₂/HR) adjusted for order, sex, height and weight. HF, chronic heart failure; CCS, acute/chronic coronary syndrome; $\dot{\mathrm{V}}$O₂, oxygen consumption; HR, heart rate; $\dot{\mathrm{V}}$O₂/HR, oxygen pulse.

Figure 4

Figure 4. Barplots of within-subject differences between oral and nasal breathing (oral value–nasal value) for the same parameters as shown in Figure 2.

Patients with CCS had similar values to patients with HF for all measured parameters and similar improvements with nasal breathing (Figures 2, 3). Five patients with HF and one patient with CCS had EOV during oral breathing which in all these patients was markedly dampened with nasal breathing (Figure 5).

Figure 5

Figure 5. Example of ventilation and tidal volume of a typical female 63 years old patient with heart failure with reduced ejection fraction. The mask was not worn during the 10 min rest phase between exercise bouts.

Based on selection criteria, the young and old healthy group had lower $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂-ratio during both breathing modes (Graphical abstract). Associated with this higher ventilatory efficiency were lower P_ETO₂ levels and higher P_ETCO₂ levels. Patients with HF had lower V_T (p = 0.003) and patients with CCS tended to have lower V_T (p = 0.062) than old healthy volunteers (Supplementary Table S2). Sex was not a significant factor in any of the models (Supplementary Table S2).

4 Discussion

Our study is the first to demonstrate that nasal breathing could reduce the excessive ventilatory response to exercise (represented by a lower $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂-ratio) by significantly lowering f_R and increasing V_T, leading to a greatly reduced RSBI in patients with HF and CCS. It is noteworthy that 93% of patients with CHF and 80% of those with CCS improved their ventilatory efficiency with nasal compared to oral breathing (and 93% in controls, for summary see Figure 6). Concomittantly, P_ETCO₂ levels were raised and P_ETO₂ levels reduced, indicating improved gas exchange likely due to reduced physiologic dead space. In 6 patients with EOV during oral breathing, nasal breathing markedly reduced the amplitudes in ventilation. The differences between breathing modes had large effect sizes and were consistent in all groups, suggesting that the difference between nasal and oral breathing is not disease-specific and independent of age.

Nasal breathing compared to oral breathing lowered $\dot{\mathrm{V}}$_E and f_R and increased V_T in all groups. As a consequence, RSBI was reduced by 34.5% with nasal breathing in the HF group, indicating that abnormal breathing patterns can be largely normalized in these patients (reaching almost the median of the old control subjects with oral breathing, Table 2). RSB increases anatomical dead space, with the consequence that P_ETCO₂ increasingly underestimates P_aCO₂ (McSwain et al., 2010). Dead space is composed of anatomical and physiologic dead space, with the latter being large due to ventilation-perfusion mismatch based on reduced perfusion and/or edematous lung parenchyma in heart patients (Cross et al., 2020). Anatomical dead space of nasal breathing has been found to be approximately 0.03 L greater than oral breathing (Tanaka et al., 1985). An increased anatomical dead space has been found to lead to increased ventilation (Ward and Whipp, 1980). Contrarily and in accordance with Douglas and colleagues (Douglas et al., 1983) we found a decrease in ventilatory drive with nasal as compared to oral breathing. While we cannot calculate dead space in the absence of blood gas analyses, the improvement of ventilatory efficiency in all patients with CHF and over 90% of all subjects tested in the present study indicates a reduction rather than an increase in pulmonary dead space.

In our CHF group, median $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂ was reduced by 3.6, which is comparable to the reduction of 3.7 found with a 3-month thrice weekly high-intensity interval training (HIIT), (Donelli da Silveira et al., 2020), greater than the 2.0 found in a similar study (Iellamo et al., 2013) but less than the 5.3 found in a 16-week thrice weekly HIIT (Smart and Steele, 2012). Ventilatory efficiency was improved by 9% in our patients with HF by an acute bout of nasal breathing, which compares well against the achieved 14% by 6 months of taking enalapril (Guazzi et al., 1999).

Our results are consistent with findings of previous studies in healthy individuals, where acute nasal breathing was found to reduce $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂-ratio by approximately 10% compared to acute oral breathing (Dallam et al., 2018; LaComb et al., 2017).

$\dot{\mathrm{V}}$_E and f_R were reduced with nasal breathing most likely as a result of increased airway resistance, as has been previously shown in healthy volunteers (Rappelt et al., 2023; Shi et al., 1999). Since median $\dot{\mathrm{V}}$O₂ were higher with nasal breathing in all groups, this most likely lead to also higher $\dot{\mathrm{V}}$CO₂, which would have partly been responsible for the reduced $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂ ratio. The greater V_T probably caused a greater oxygen demand by the diaphragm and other breathing muscles. In contrast, in the studies by Dallam and colleagues as well as by Rappelt and colleagues $\dot{\mathrm{V}}$O₂ was decreased with nasal breathing during steady state submaximal exercise compared to oral breathing, suggesting that less metabolic energy was required to complete the same work (Dallam et al., 2018; Rappelt et al., 2023). We suggest that differences in oxygen demand between their and our study may be explained by the fact that their subjects were selected from a population of recreational athletes well adapted to nasal breathing (performing their regular running training with nasal breathing) while our subjects were not specifically selected with regard to habitual breathing mode. It is possible that adequate training of the diaphragm may be needed to adapt the diaphragm to the changed force-length relationship at a greater V_T in order to achieve adequate economization of energy demand and hence $\dot{\mathrm{V}}$O₂. On the other hand, lower lung compliance in patients with HF (Cross et al., 2020) would also explain the higher oxygen demand by the diaphragm with increasing V_T. Despite the higher $\dot{\mathrm{V}}$O₂ with nasal breathing in our subjects, respiratory quotient and RPE did not differ between nasal and oral breathing.

Potential mechanisms underlying the improvement of ventilatory efficiency with nasal breathing may be the alteration of breathing pattern with lower f_R and increased V_T, with the latter having been shown to reduce muscle sympathetic neural activation in some (Hering et al., 2013; Oneda et al., 2010) but not all studies (Limberg et al., 2013). Another potential mechanism reducing $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$ CO₂ with nasal breathing may be the airflow (particularly with cool air) through the nose that stimulates upper airway receptors which have been shown to dampen ventilatory drive (McBride and Whitelaw, 1981).

The increase in P_ETCO₂ and decrease in P_ETO₂ with nasal breathing indicates either a more efficient oxygen extraction or a better reflection of alveolar partial pressures of CO₂ and O₂, based on the fact that breathing at higher f_R increases the ratio of air that goes to anatomical dead space. Further, nasal breathing has been suggested to lead to higher nitric oxide (NO) concentrations in the inhaled air than oral breathing as the main production site of NO, the paranasal sinuses, are circumvented by oral breathing (Lundberg et al., 1996; Lundberg et al., 1995). Nasal breathing has been shown to reduce pulmonary vascular resistance compared to oral breathing in an invasive study in patients with HF (Settergren et al., 1998). Inhaled NO, which is recommended intraoperatively in patients with pulmonary hypertension for selective pulmonary vasodilation, (Rajagopal et al., 2023), and during cardiopulmonary bypass, (Abouzid et al., 2023), has been shown to improve ventilation-perfusion matching (Dembinski et al., 2000; Hoffman and Nelin, 2005; Hajian et al., 2016).

It has been suggested that the rapid shallow breathing pattern may be adapted by patients with HF to avoid large intrathoracic pressure swings to preserve cardiac output (Lalande and Johnson, 2010). In our study, the O₂ pulse, an accepted surrogate parameter for stroke volume, was not found to be different between nasal and oral breathing in neither of our patient groups, so we cannot confirm that a greater V_T leads to a reduction of stroke volume in these patients.

Strengths of the present study were the inclusion of a representative cohort of well phenotyped patients with CHF and CCS and a rigorous within-subject study protocol, CPET based measurements, and random assignment of the order of the intervention to each study participant. Further, the inclusion of both sexes as well as a young healthy control group showed that the found effects of nasal breathing were independent of sex and age and similarly applied to all groups.

In the present study, we set the intensity at 50% of the maximal power despite results by LaComb and colleagues in healthy people suggesting that the effects of nasal breathing on reducing $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂-ratio may be greater at intensities higher than 50% (LaComb et al., 2017). However, 50% of maximal power output corresponded to the first ventilatory threshold and hence for the intensity recommended for patients with HF and CCS (McDonagh et al., 2021; Knuuti et al., 2020).

The main limitation of our study was the lack of blood gas analyses due to logistic reasons, which prevented calculation of dead space. A further limitation was that no dyspnea perception rating was included, so we can only assume from the RPE that patients subjectively felt the same amount of dyspnea during both trials. Also, the chosen bout duration was 5 min in this study for logistic reasons so that all patients managed to perform two bouts during one visit to the lab. Whether the same differences between breathing modes would result from longer bouts would have to be tested in a more involving study protocol with bouts on separate days. Last but not least, since we only included patients with $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂ slopes ≥36, we cannot extrapolate our findings to patients with only mildly increased ventilatory inefficiency, however, the consistency of our findings across all our groups suggests that the effect of nasal breathing would be similar.

We conclude that in healthy subjects and patients with HF or CCS alike, nasal breathing led to a reduced $\dot{\mathrm{V}}$_E/$\dot{\mathrm{V}}$CO₂ ratio, reduced f_R and increased V_T compared to oral breathing at moderate exercise intensity. The improved gas exchange and breathing pattern in patients with HF or CCS suggests that nasal breathing should be the recommended breathing mode at moderate exercise intensities in patients with inefficient ventilation.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving humans were approved by the Ethikkommission des Kantons Bern. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

PE: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing–original draft, Writing–review and editing. PC: Data curation, Formal Analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing–review and editing. AK: Investigation, Methodology, Project administration, Visualization, Writing–review and editing. LS: Project administration, Visualization, Writing–review and editing. SH: Investigation, Methodology, Project administration, Writing–review and editing. DK: Investigation, Methodology, Project administration, Writing–review and editing. SG: Writing–review and editing. MW: Conceptualization, Investigation, Resources, Supervision, Writing–review and editing.

Funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphys.2024.1380562/full#supplementary-material

SUPPLEMENTARY FIGURE S1 | Protocol of study measurements comparing oral and nasal breathing at 50% or peak power output that was determined during a preceding maximal ramp test. *order of oral and nasal breathing was set randomly.

Abbreviations

BMI, body mass index; BSA, body surface area; CCS, chronic coronary syndrome; CO₂, carbon dioxide; CPET, cardiopulmonary exercise test; EOV, exercise oscillatory ventilation; FCV, forced vital capacity; FEV₁, forced expiratory volume in the first second; f_R, respiratory frequency; HF, heart failure; HFpEF; heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; HR, heart rate; O₂, oxygen; P_aCO₂, arterial partial pressure of carbon dioxide; P_aO₂, arterial partial pressure of oxygen; P_ETCO_2, end-tidal partial pressure of carbon dioxide; P_ETO₂, end-tidal partial pressure of oxygen; RER, $\dot{\mathrm{V}}$CO₂/$\dot{\mathrm{V}}$O₂; RPE, rate of perceived exertion; RSBI, rapid shallow breathing index; SpO₂, oxygen saturation; V_D, pulmonary dead space; $\dot{\mathrm{V}}$_E, ventilation; $\dot{\mathrm{V}}$CO₂, carbon dioxide production; $\dot{\mathrm{V}}$O₂, oxygen production; V_T, tidal volume; VT1, first ventilatory threshold, VT2, second ventilatory threshold.

References

Abouzid M., Roshdy Y., Daniel J. M., Rzk F. M., Ismeal A. A. A., Hendawy M., et al. (2023). The beneficial use of nitric oxide during cardiopulmonary bypass on postoperative outcomes in children and adult patients: a systematic review and meta-analysis of 2897 patients. Eur. J. Clin. Pharmacol. 79, 1425–1442. doi:10.1007/s00228-023-03554-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Agostoni P., Guazzi M. (2017). Exercise ventilatory inefficiency in heart failure: some fresh news into the roadmap of heart failure with preserved ejection fraction phenotyping. Eur. J. heart Fail. 19 (12), 1686–1689. doi:10.1002/ejhf.940

PubMed Abstract | CrossRef Full Text | Google Scholar

Arena R., Myers J., Aslam S. S., Varughese E. B., Peberdy M. A. (2004). Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am. heart J. 147 (2), 354–360. doi:10.1016/j.ahj.2003.07.014

PubMed Abstract | CrossRef Full Text | Google Scholar

Bernardi L., Porta C., Spicuzza L., Bellwon J., Spadacini G., Frey A. W., et al. (2002). Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure. Circulation 105 (2), 143–145. doi:10.1161/hc0202.103311

PubMed Abstract | CrossRef Full Text | Google Scholar

Chua T. P., Clark A. L., Amadi A. A., Coats A. J. (1996). Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J. Am. Coll. Cardiol. 27 (3), 650–657. doi:10.1016/0735-1097(95)00523-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Cooper L. B., Mentz R. J., Sun J. L., Schulte P. J., Fleg J. L., Cooper L. S., et al. (2015). Psychosocial factors, exercise adherence, and outcomes in heart failure patients: insights from heart failure: a controlled trial investigating outcomes of exercise training (HF-action). Circ. Heart Fail. 8 (6), 1044–1051. doi:10.1161/CIRCHEARTFAILURE.115.002327

PubMed Abstract | CrossRef Full Text | Google Scholar

Cross T. J., Kim C. H., Johnson B. D., Lalande S. (2020). The interactions between respiratory and cardiovascular systems in systolic heart failure. J. Appl. Physiol. (1985) 128 (1), 214–224. doi:10.1152/japplphysiol.00113.2019

PubMed Abstract | CrossRef Full Text | Google Scholar

Dallam G., Kies B. (2020). The effect of nasal breathing versus oral and oronasal breathing during exercise: a review. J. Sports Res. 7 (1), 1–10. doi:10.18488/journal.90.2020.71.1.10

CrossRef Full Text | Google Scholar

Dallam G., McClaran S., Cox D., P. Foust C. (2018). Effect of nasal versus oral breathing on Vo2max and physiological economy in recreational runners following an extended period spent using nasally restricted breathing. Int. J. Kinesiol. Sports Sci. 6 (2), 22–29. doi:10.7575/aiac.ijkss.v.6n.2p.22

CrossRef Full Text | Google Scholar

Dembinski R., Max M., Lopez F., Kuhlen R., Sünner M., Rossaint R. (2000). Effect of inhaled nitric oxide in combination with almitrine on ventilation-perfusion distributions in experimental lung injury. Intensive Care Med. 26 (2), 221–228. doi:10.1007/s001340050051

PubMed Abstract | CrossRef Full Text | Google Scholar

Donelli da Silveira A., Beust de Lima J., da Silva Piardi D., Dos Santos Macedo D., Zanini M., Nery R., et al. (2020). High-intensity interval training is effective and superior to moderate continuous training in patients with heart failure with preserved ejection fraction: a randomized clinical trial. Eur. J. Prev. Cardiol. 27 (16), 1733–1743. doi:10.1177/2047487319901206

PubMed Abstract | CrossRef Full Text | Google Scholar

Douglas N. J., White D. P., Weil J. V., Zwillich C. W. (1983). Effect of breathing route on ventilation and ventilatory drive. Respir. Physiol. 51 (2), 209–218. doi:10.1016/0034-5687(83)90041-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Eser P., Marcin T., Prescott E., Prins L. F., Kolkman E., Bruins W., et al. (2023). Breathing pattern and pulmonary gas exchange in elderly patients with and without left ventricular dysfunction—modification with exercise-based cardiac rehabilitation and prognostic value. Front. Cardiovasc. Med. 10, 1219589. doi:10.3389/fcvm.2023.1219589

PubMed Abstract | CrossRef Full Text | Google Scholar

Eser P., Trachsel L. D., Marcin T., Herzig D., Freiburghaus I., De Marchi S., et al. (2022). Short- and long-term effects of high-intensity interval training vs. Moderate-intensity continuous training on left ventricular remodeling in patients early after ST-segment elevation myocardial infarction-the HIIT-EARLY randomized controlled trial. Front. Cardiovasc Med. 9, 869501. doi:10.3389/fcvm.2022.869501

PubMed Abstract | CrossRef Full Text | Google Scholar

Glaab T., Taube C. (2022). Practical guide to cardiopulmonary exercise testing in adults. Respir. Res. 23 (1), 9. doi:10.1186/s12931-021-01895-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Guazzi M., Adams V., Conraads V., Halle M., Mezzani A., Vanhees L., et al. (2012). EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 126 (18), 2261–2274. doi:10.1161/CIR.0b013e31826fb946

PubMed Abstract | CrossRef Full Text | Google Scholar

Guazzi M., Melzi G., Marenzi G. C., Agostoni P. (1999). Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction. Clin. Pharmacol. Ther. 65 (3), 319–327. doi:10.1016/S0009-9236(99)70111-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Hajian B., De Backer J., Vos W., Van Holsbeke C., Ferreira F., Quinn D. A., et al. (2016). Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension. Int. J. Chron. Obstruct Pulmon Dis. 11, 1533–1541. doi:10.2147/COPD.S106480

PubMed Abstract | CrossRef Full Text | Google Scholar

Hambrecht R., Niebauer J., Fiehn E., Kälberer B., Offner B., Hauer K., et al. (1995). Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J. Am. Coll. Cardiol. 25 (6), 1239–1249. doi:10.1016/0735-1097(94)00568-B

PubMed Abstract | CrossRef Full Text | Google Scholar

Hering D., Kucharska W., Kara T., Somers V. K., Parati G., Narkiewicz K. (2013). Effects of acute and long-term slow breathing exercise on muscle sympathetic nerve activity in untreated male patients with hypertension. J. Hypertens. 31 (4), 739–746. doi:10.1097/HJH.0b013e32835eb2cf

PubMed Abstract | CrossRef Full Text | Google Scholar

Hoffman G. M., Nelin L. D. (2005). Mean airway pressure and response to inhaled nitric oxide in neonatal and pediatric patients. Lung 183 (6), 441–453. doi:10.1007/s00408-005-2555-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Iellamo F., Manzi V., Caminiti G., Vitale C., Castagna C., Massaro M., et al. (2013). Matched dose interval and continuous exercise training induce similar cardiorespiratory and metabolic adaptations in patients with heart failure. Int. J. Cardiol. 167 (6), 2561–2565. doi:10.1016/j.ijcard.2012.06.057

PubMed Abstract | CrossRef Full Text | Google Scholar

Knuuti J., Wijns W., Saraste A., Capodanno D., Barbato E., Funck-Brentano C., et al. (2020). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. heart J. 41 (3), 407–477. doi:10.1093/eurheartj/ehz425

PubMed Abstract | CrossRef Full Text | Google Scholar

Lachowska K., Bellwon J., Narkiewicz K., Gruchała M., Hering D. (2019). Long-term effects of device-guided slow breathing in stable heart failure patients with reduced ejection fraction. Clin. Res. Cardiol. official J. Ger. Cardiac Soc. 108 (1), 48–60. doi:10.1007/s00392-018-1310-7

PubMed Abstract | CrossRef Full Text | Google Scholar

LaComb C. O., Tandy R. D., Lee S.-P., Young J. C., Navalta J. W. (2017). Oral versus nasal breathing during moderate to high intensity submaximal aerobic exercise. Int. J. Kinesiol. Sports Sci. 5, 8–16. doi:10.7575//aiac.ijkss.v.5n.1p.8

CrossRef Full Text | Google Scholar

Lalande S., Johnson B. D. (2010). Breathing strategy to preserve exercising cardiac function in patients with heart failure. Med. Hypotheses 74 (3), 416–421. doi:10.1016/j.mehy.2009.09.030

PubMed Abstract | CrossRef Full Text | Google Scholar

Limberg J. K., Morgan B. J., Schrage W. G., Dempsey J. A. (2013). Respiratory influences on muscle sympathetic nerve activity and vascular conductance in the steady state. Am. J. Physiol. Heart Circ. Physiol. 304 (12), H1615–H1623. doi:10.1152/ajpheart.00112.2013

PubMed Abstract | CrossRef Full Text | Google Scholar

Lundberg J. O., Lundberg J. M., Settergren G., Alving K., Weitzberg E. (1995). Nitric oxide, produced in the upper airways, may act in an 'aerocrine' fashion to enhance pulmonary oxygen uptake in humans. Acta physiol. Scand. 155 (4), 467–468. doi:10.1111/j.1748-1716.1995.tb09998.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Lundberg J. O., Settergren G., Gelinder S., Alving K., Weitzberg E. (1996). Inhalation of nasally derived nitric oxide modulates pulmonary function in humans. Acta physiol. Scand. 158 (4), 343–347. doi:10.1046/j.1365-201X.1996.557321000.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Marcin T., Eser P., Prescott E., Prins L. F., Kolkman E., Bruins W., et al. (2020). Training intensity and improvements in exercise capacity in elderly patients undergoing European cardiac rehabilitation - the EU-CaRE multicenter cohort study. PloS one 15 (11), e0242503. doi:10.1371/journal.pone.0242503

PubMed Abstract | CrossRef Full Text | Google Scholar

McBride B., Whitelaw W. A. (1981). A physiological stimulus to upper airway receptors in humans. J. Appl. Physiol. Respir. Environ. Exerc Physiol. 51 (5), 1189–1197. doi:10.1152/jappl.1981.51.5.1189

PubMed Abstract | CrossRef Full Text | Google Scholar

McDonagh T. A., Metra M., Adamo M., Gardner R. S., Baumbach A., Böhm M., et al. (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. heart J. 42 (36), 3599–3726. doi:10.1093/eurheartj/ehab368

PubMed Abstract | CrossRef Full Text | Google Scholar

McSwain S. D., Hamel D. S., Smith P. B., Gentile M. A., Srinivasan S., Meliones J. N., et al. (2010). End-tidal and arterial carbon dioxide measurements correlate across all levels of physiologic dead space. Respir. Care 55 (3), 288–293.

PubMed Abstract | Google Scholar

Nadruz W., West E., Sengelov M., Santos M., Groarke J. D., Forman D. E., et al. (2017). Prognostic value of cardiopulmonary exercise testing in heart failure with reduced, midrange, and preserved ejection fraction. J. Am. Heart Assoc. 6 (11), e006000. doi:10.1161/JAHA.117.006000

PubMed Abstract | CrossRef Full Text | Google Scholar

Oneda B., Ortega K. C., Gusmão J. L., Araújo T. G., Mion D. (2010). Sympathetic nerve activity is decreased during device-guided slow breathing. Hypertens. Res. 33 (7), 708–712. doi:10.1038/hr.2010.74

PubMed Abstract | CrossRef Full Text | Google Scholar

Parati G., Malfatto G., Boarin S., Branzi G., Caldara G., Giglio A., et al. (2008). Device-guided paced breathing in the home setting: effects on exercise capacity, pulmonary and ventricular function in patients with chronic heart failure: a pilot study. Circ. Heart Fail. 1 (3), 178–183. doi:10.1161/CIRCHEARTFAILURE.108.772640

PubMed Abstract | CrossRef Full Text | Google Scholar

Piepoli M., Clark A. L., Volterrani M., Adamopoulos S., Sleight P., Coats A. J. (1996). Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation 93 (5), 940–952. doi:10.1161/01.cir.93.5.940

PubMed Abstract | CrossRef Full Text | Google Scholar

Ponikowski P., Chua T. P., Piepoli M., Ondusova D., Webb-Peploe K., Harrington D., et al. (1997). Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 96 (8), 2586–2594. doi:10.1161/01.cir.96.8.2586

PubMed Abstract | CrossRef Full Text | Google Scholar

Ponikowski P. P., Chua T. P., Francis D. P., Capucci A., Coats A. J., Piepoli M. F. (2001). Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation 104 (19), 2324–2330. doi:10.1161/hc4401.098491

PubMed Abstract | CrossRef Full Text | Google Scholar

Rajagopal S., Ruetzler K., Ghadimi K., Horn E. M., Kelava M., Kudelko K. T., et al. (2023). Evaluation and management of pulmonary hypertension in noncardiac surgery: a scientific statement from the American heart association. Circulation 147 (17), 1317–1343. doi:10.1161/CIR.0000000000001136

PubMed Abstract | CrossRef Full Text | Google Scholar

Rappelt L., Held S., Wiedenmann T., Deutsch J. P., Hochstrate J., Wicker P., et al. (2023). Restricted nasal-only breathing during self-selected low intensity training does not affect training intensity distribution. Front. physiology 14, 1134778. doi:10.3389/fphys.2023.1134778

PubMed Abstract | CrossRef Full Text | Google Scholar

Settergren G., Angdin M., Astudillo R., Gelinder S., Liska J., Lundberg J. O., et al. (1998). Decreased pulmonary vascular resistance during nasal breathing: modulation by endogenous nitric oxide from the paranasal sinuses. Acta physiol. Scand. 163 (3), 235–239. doi:10.1046/j.1365-201x.1998.00352.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Shi Y. X., Seto-Poon M., Wheatley J. R. (1999). The breathing route dependence of ventilatory responses to hypercapnia and exercise is modulated by upper airway resistance. Respirology 4 (4), 331–338. doi:10.1046/j.1440-1843.1999.00201.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Smart N. A., Steele M. (2012). A comparison of 16 weeks of continuous vs intermittent exercise training in chronic heart failure patients. Congest. Heart Fail 18 (4), 205–211. doi:10.1111/j.1751-7133.2011.00274.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Tanaka Y., Morikawa T., Honda Y. (1988). An assessment of nasal functions in control of breathing. J. Appl. Physiol.(1985) 65 (4), 1520–1524. doi:10.1152/jappl.1988.65.4.1520

PubMed Abstract | CrossRef Full Text | Google Scholar

Tomita T., Takaki H., Hara Y., Sakamaki F., Satoh T., Takagi S., et al. (2003). Attenuation of hypercapnic carbon dioxide chemosensitivity after postinfarction exercise training: possible contribution to the improvement in exercise hyperventilation. Heart 89 (4), 404–410. doi:10.1136/heart.89.4.404

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang M. C., Corbridge T. C., McCrimmon D. R., Walter J. M. (2020). Teaching an intuitive derivation of the clinical alveolar equations: mass balance as a fundamental physiological principle. Adv. Physiol. Educ. 44 (2), 145–152. doi:10.1152/advan.00064.2019

PubMed Abstract | CrossRef Full Text | Google Scholar

Ward S. A., Whipp B. J. (1980). Ventilatory control during exercise with increased external dead space. J. Appl. Physiol. Respir. Environ. Exerc Physiol. 48 (2), 225–231. doi:10.1152/jappl.1980.48.2.225

PubMed Abstract | CrossRef Full Text | Google Scholar

Weatherald J., Sattler C., Garcia G., Laveneziana P. (2018). Ventilatory response to exercise in cardiopulmonary disease: the role of chemosensitivity and dead space. Eur. Respir. J. 51 (2), 1700860. doi:10.1183/13993003.00860-2017

PubMed Abstract | CrossRef Full Text | Google Scholar